Back to search
FDAFDA · Food and drugs·Recall number D-0223-2024

Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-180-15

Published January 17, 2024 · Recall initiated: January 2, 2024

Summary

FDA records drug Class II recall D-0223-2024, published January 17, 2024 and initiated January 2, 2024. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Completed; Reported quantity: 38,952 bottles; Lot: Lot #: T2304007, Exp 7/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.

What to do

Voluntary: Firm initiated · Letter

Get an email if TIZANIDINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TIZANIDINE
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
USA Nationwide
UPC
0355111180104
Lot
Lot #: T2304007, Exp 7/31/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-180-15 recalled?

Yes. FDA published recall D-0223-2024 on January 17, 2024. Reported hazard: Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TIZANIDINE. UPC: 0355111180104.